What's Next When Treatment for Triple-Negative Breast Cancer Stops Working?

Treatment for triple-negative breast cancer has advanced significantly, but challenges remain when, in some cases, the disease returns after treatment. In this episode, we sit down with Dr Belinda Yeo to explore treatment options for triple-negative breast cancer patientswhose cancer has that has relapsed. Dr Yeo discusses the challenges clinicians face when deciding what treatment to offer next, emerging therapies showingpromise, and the critical role that clinical trials continue to play in improving outcomes for people with triple-negative breast cancer. (3:03) If a patient's cancer does return after these therapies, what are clinicians' biggest challenges in determining what treatment to offer next? (04:21) As a clinician, what treatment approaches or emerging therapies for triple-negative breast cancer are giving you the most optimism? (06:05) How important is participation in clinical trials? (07:21) What is one key message that you'd like patients navigating triple-negative breast cancer to take away from this episode? Tune in for a deep dive into this important research. Like this episode? ⁠⁠ Follow Breast Cancer Trials on Social Media:  Instagram:⁠ @breastcancertrials Facebook:⁠ ⁠Breast Cancer Trials LinkedIn: Breast Cancer Trials X: ⁠⁠@BCTrialsANZ Guest: Medical Oncologist, Dr Belinda Yeo. Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about the importance of clinical trials research.